{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T23:02:36Z","timestamp":1794697356600,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1493-1","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T21:53:47Z","timestamp":1474322027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-1870","authenticated-orcid":false,"given":"Maru","family":"Aregawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Sillah-Kanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Seppeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitta R. Y.","family":"Kamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Aponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"1493_CR1","unstructured":"United Nations Populations prospects. 2015. http:\/\/esa.un.org\/unpd\/wpp\/publications\/files\/key_findings_wpp_2015.pdf . Accessed 04 Dec 2015."},{"key":"1493_CR2","unstructured":"Sierra Leone Malaria Indicator Survey 2013. National Malaria Control Programme (NMCP) [Sierra Leone] Statistics Sierra Leone University of Sierra Leone Catholic Relief Services and ICF International. Freetown, Sierra Leone: NMCP, SSL, CRS, and ICF International; 2013."},{"key":"1493_CR3","volume-title":"Statistics Sierra Leone (SSL) and ICF International","author":"Sierra Leone demographic and health survey 2013","year":"2014","unstructured":"Sierra Leone demographic and health survey 2013. Statistics Sierra Leone (SSL) and ICF International. Sierra Leone: SSL and ICF International; 2014."},{"key":"1493_CR4","unstructured":"WHO. World malaria report 2014. Geneva: World Health Organization; 2014; http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2014\/en\/ . Accessed 23 June 2015."},{"key":"1493_CR5","unstructured":"Ministry of Health and Sanitation, Sierra Leone (MoHS). 2015. http:\/\/health.gov.sl\/wp-content\/uploads\/2015\/08\/Ebola-Update-August-12-2015.pdf . Accessed 03 Nov 2015."},{"key":"1493_CR6","volume-title":"Sierra Leone (MoHS)","author":"Ministry of Health and Sanitation","year":"2014","unstructured":"Ministry of Health and Sanitation. Sierra Leone (MoHS). Sierra Leone: Health Facility; 2014."},{"key":"1493_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1473-3099(15)70124-6","volume":"15","author":"PG Walker","year":"2015","unstructured":"Walker PG, White MT, Griffin JT, Reynolds A, Ferguson NM, Ghani AC. Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity and the potential effect of mitigation strategies: a modelling analysis. Lancet Infect Dis. 2015;15:825\u201332.","journal-title":"Lancet Infect Dis."},{"key":"1493_CR8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S1473-3099(15)00061-4","volume":"15","author":"MM Plucinski","year":"2015","unstructured":"Plucinski MM, Guilavogui T, Sidikiba S, Diakit\u00e9 N, Diakit\u00e9 S, Dioubat\u00e9 M, et al. Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea 2014: a cross-sectional survey of health facilities. Lancet Infect Dis. 2015;15:1017\u201323.","journal-title":"Lancet Infect Dis."},{"key":"1493_CR9","unstructured":"WHO. Guidance on temporary malaria control measures in Ebola-affected countries. Geneva: World Health Organization; 2014. http:\/\/www.who.int\/malaria\/publications\/atoz\/malariacontrol-ebola-affected-countries\/en\/ . Accessed 23 June 2015."},{"key":"1493_CR10","unstructured":"Ministry of Health and Sanitation. LLIN Mass Campaign report 2014. National Malaria Control Programme; 2014."},{"key":"1493_CR11","unstructured":"WHO. Case definition recommendations for Ebola or Marburg virus diseases. Geneva: World Health Organization; 2014. http:\/\/apps.who.int\/iris\/bitstream\/10665\/146397\/1\/WHO_EVD_CaseDef_14.1_eng.pdf?ua=1&ua=1 . Accessed 09 Aug 2014."},{"key":"1493_CR12","unstructured":"Stata Corporation. 2015. http:\/\/www.stata.com\/new-in-stata\/ . Accessed 23 Nov 2015."},{"key":"1493_CR13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jclinepi.2008.08.007","volume":"62","author":"F Zhang","year":"2009","unstructured":"Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol. 2009;62:143\u20138.","journal-title":"J Clin Epidemiol"},{"key":"1493_CR14","volume-title":"Report of the Independent Monitors of the Malaria Mass Drug Administration for Artesunate Amodiaquine (ASAQ)","author":"Ministry of Health and Sanitation, Sierra Leone","year":"2015","unstructured":"Ministry of Health and Sanitation, Sierra Leone. Report of the Independent Monitors of the Malaria Mass Drug Administration for Artesunate Amodiaquine (ASAQ). Sierra Leone: Ministry of Health and Sanitation; 2015."},{"key":"1493_CR15","unstructured":"Ministry of Health and Sanitation, Sierra Leone. Report on adverse drug reaction (ADA) of the ASAQ used for the Malaria Mass Drug Administration Pharmacovigilance Team Board of Pharmacy and MoHS. Sierra Leone; 2015."},{"key":"1493_CR16","volume-title":"National Malaria Control Programme","author":"Ministry of Health and Sanitation, Sierra Leone. Results of the Mass Drug Administration (MDA) in response to the Ebola outbreak, December to","year":"2015","unstructured":"Ministry of Health and Sanitation, Sierra Leone. Results of the Mass Drug Administration (MDA) in response to the Ebola outbreak, December to. National Malaria Control Programme. Sierra Leone: Ministry of Health and Sanitation; 2015."},{"key":"1493_CR17","first-page":"205","volume-title":"Guidelines for treatment of malaria","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Guidelines for treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015. p. 205\u20136.","edition":"3"},{"key":"1493_CR18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-3156.2004.01367.x","volume":"10","author":"F Checchi","year":"2005","unstructured":"Checchi F, Roddy P, Kamara S, Williams A, Morineau G, Wurie AR, et al. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine\u2013pyrimethamine and amodiaquine. Trop Med Int Health. 2005;10:146\u201353.","journal-title":"Trop Med Int Health."},{"key":"1493_CR19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4269\/ajtmh.1980.29.725","volume":"29","author":"L Molineaux","year":"1980","unstructured":"Molineaux L, Storey J, Cohen JE, Thomas A. A longitudinal study of human malaria in the West African Savanna in the absence of control measures: relationships between different Plasmodium species in particular P. falciparum and P. malariae. Am J Trop Med Hyg. 1980;29:725\u201337.","journal-title":"Am J Trop Med Hyg."},{"key":"1493_CR20","unstructured":"Medecins Sans Frontieres (MSF). Report on performance and time to become negative of three malaria rapid diagnostic tests for in children under 5\u00a0years of age. Evaluation in two different malaria epidemiological settings in Greater Mbarara district, Uganda; 2012\u201313."},{"key":"1493_CR21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/526502","volume":"197","author":"H Hopkins","year":"2008","unstructured":"Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G. Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis. 2008;197:510\u20138.","journal-title":"J Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1493-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T19:11:46Z","timestamp":1498331506000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1493-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1493-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]},"article-number":"480"}}